UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 169.736

Sortiert nach

0.6 T magnetic resonance imaging of the orbit

American journal of roentgenology (1976), 1985-05, Vol.144 (5), p.1015

1985

Link zum Volltext

Verfügbarkeit prüfen

0-7-21 radiation therapy for the treatment of canine oral melanoma

Journal of veterinary internal medicine, 1994-07, Vol.8 (4), p.267-272

1994

Link zum Volltext

Verfügbarkeit prüfen

0‐7‐21 radiotherapy in nodular melanoma

Cancer, 1983-01, Vol.51 (2), p.226-232

1983

Link zum Volltext

Verfügbarkeit prüfen

0306: Melanoma Antigen Gene (Mage) Can Be a Good Target of Immunotherapy in Old Patients with Aggressive Ovarian Cancer

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.687-687

2006

Link zum Volltext

Verfügbarkeit prüfen

0470: Lymph Node Ratio (Lnr) is a Usefull Prognostic Factor in Node-Positive Primary Vulvar Malignant Melanoma (Pvmm)

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.733-733

2006

Link zum Volltext

Verfügbarkeit prüfen

0527: Primary Melanoma of the Uterine Cervix

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.748-748

2006

Link zum Volltext

Verfügbarkeit prüfen

0542: Malignant Vaginal Melanoma: a Case Report

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.752-752

2006

Link zum Volltext

Verfügbarkeit prüfen

0554: Malignant Melanoma of the Vagina - Analysis of Prognostic Factors

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.755-755

2006

Link zum Volltext

Verfügbarkeit prüfen

062 Pembrolizumab induced lambert-eaton myasthenic syndrome

BMJ neurology open, 2021-08, Vol.3 (Suppl 1), p.A22-A23

2021

Link zum Volltext

Verfügbarkeit prüfen

09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A4-A5

2022

Link zum Volltext

Verfügbarkeit prüfen

09.04 Secondary resistance to immunotherapy is associated with death and de-differentiation of activated T cells

Journal for immunotherapy of cancer, 2022-09, Vol.10 (Suppl 1), p.A5-A6

2022

Link zum Volltext

Verfügbarkeit prüfen

0D/2D heteronanostructure–integrated bimetallic CoCu-ZIF nanosheets and MXene-derived carbon dots for impedimetric cytosensing of melanoma B16-F10 cells

Mikrochimica acta (1966), 2021-03, Vol.188 (3), p.69-69, Article 69

2021

Link zum Volltext

Verfügbarkeit prüfen

1,2,3-Triazolyl esterization of PAK1-blocking propolis ingredients, artepillin C (ARC) and caffeic acid (CA), for boosting their anti-cancer/anti-PAK1 activities along with cell-permeability

Drug Discoveries & Therapeutics, 2017/04/30, Vol.11(2), pp.104-109

2017

Link zum Volltext

Verfügbarkeit prüfen

1-(2,4-Dihydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)propane, a Novel Tyrosinase Inhibitor with Strong Depigmenting Effects

Chemical and Pharmaceutical Bulletin, 2008/09/01, Vol.56(9), pp.1292-1296

2008

Link zum Volltext

Verfügbarkeit prüfen

1,2,4-Trimethoxybenzene selectively inhibits NLRP3 inflammasome activation and attenuates experimental autoimmune encephalomyelitis

Acta pharmacologica Sinica, 2021-11, Vol.42 (11), p.1769-1779

2021

Link zum Volltext

Verfügbarkeit prüfen

1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M) : A novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity

Cancer research (Chicago, Ill.), 2001-04, Vol.61 (7), p.3033-3038

2001

Link zum Volltext

Verfügbarkeit prüfen

1,2-Bis(sulfonyl)hydrazines. 3. Effects of structural modification on antineoplastic activity

Journal of medicinal chemistry, 1987-11, Vol.30 (11), p.2157-2161

1987

Link zum Volltext

Verfügbarkeit prüfen

1,2-Dihydroxyxanthone: Effect on A375-C5 Melanoma Cell Growth Associated with Interference with THP-1 Human Macrophage Activity

Pharmaceuticals (Basel, Switzerland), 2019-06, Vol.12 (2), p.85

2019

Link zum Volltext

Verfügbarkeit prüfen

1,25‐Dihydroxyvitamin D 3 enhances NK susceptibility of human melanoma cells via Hsp60‐mediated FAS expression

European journal of immunology, 2011-10, Vol.41 (10), p.2937-2946

2011

Link zum Volltext

Verfügbarkeit prüfen

1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture

Endocrinology (Philadelphia), 1981-03, Vol.108 (3), p.1083-1086

1981

Link zum Volltext

Verfügbarkeit prüfen

1,25-Dihydroxyvitamin D3 decreases expression of HLA class II molecules in a melanoma cell line

The Journal of immunology (1950), 1988-06, Vol.140 (11), p.4013

1988

Link zum Volltext

Verfügbarkeit prüfen

1,25‐Dihydroxyvitamin D3 enhances NK susceptibility of human melanoma cells via Hsp60‐mediated FAS expression

European journal of immunology, 2011-10, Vol.41 (10), p.2937-2946

2011

Link zum Volltext

Verfügbarkeit prüfen

1,25-dihydroxyvitamin D3 enhances the growth of tumors in athymic mice inoculated with receptor rich osteosarcoma cells

Biochemical and biophysical research communications, 1986-09, Vol.139 (3), p.1292-1298

1986

Link zum Volltext

Verfügbarkeit prüfen

1,25-dihydroxyvitamin D3 receptors in human carcinomas : a pilot study

Cancer research (Chicago, Ill.), 1991-04, Vol.51 (8), p.2021-2024

1991

Link zum Volltext

Verfügbarkeit prüfen

1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines

Cancer research (Chicago, Ill.), 1982-03, Vol.42 (3), p.856-859

1982

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 169.736

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133.750)
Mit Volltextzugriff
(127.119)

Publikationsform

10 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(157.212)
Japanisch
(15.203)
Deutsch
(3.785)
Französisch
(2.585)
Russisch
(1.290)
Spanisch
(1.234)
Chinesisch
(693)
Portugiesisch
(609)
Italienisch
(589)
Polnisch
(451)
Tschechisch
(252)
Niederländisch
(182)
Koreanisch
(150)
Ungarisch
(148)
Norwegisch
(144)
Schwedisch
(122)
Dänisch
(118)
Croatian
(79)
Rumänisch
(79)
Türkisch
(72)

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(113.630)
Life Sciences & Biomedicine
(105.642)
Humans
(103.963)
Melanoma
(92.550)
Female
(45.116)
Oncology
(42.580)
Male
(41.334)
Melanoma - Pathology
(36.735)
Animals
(31.423)
Middle Aged
(30.212)
Dermatology
(28.009)
Tumors
(27.764)
Adult
(25.385)
Aged
(24.510)
Biological And Medical Sciences
(24.062)
Mice
(22.984)
Cancer
(22.588)
Medical Sciences
(22.097)
Metastasis
(21.640)
Skin Neoplasms - Pathology
(21.460)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(75.863)
Ingenta
(67.106)
Lippincott E Journal Collection
(54.654)
IngentaConnect Journals
(34.640)
Single Journals
(27.499)
Wiley Online Library
(22.800)
Elsevier ScienceDirect Journals Complete
(22.045)
SpringerNature Journals
(20.087)
Wiley Online Library
(17.592)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(14.239)
Nexis
(14.093)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(10.284)
Nature
(6.796)
Factiva
(6.548)
Oxford University Press Journals Current
(4.504)
BMJ_英国医学会期刊
(3.985)
Taylor & Francis Current Content Access
(3.497)
Taylor & Francis Online
(3.469)
Jstor Complete Legacy
(2.671)
SpringerLink Series
(2.333)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(2.700)
Cancer Research
(2.586)
Reactions Weekly
(2.448)
Melanoma Research
(2.388)
Cancers
(1.995)
Dermatology Times
(1.850)
Journal Of The American Academy Of Dermatology
(1.677)
Journal For Immunotherapy Of Cancer
(1.668)
Cancer
(1.625)
International Journal Of Cancer
(1.615)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

0.6 T magnetic resonance imaging of the orbit

0-7-21 radiation therapy for the treatment of canine oral melanoma

0‐7‐21 radiotherapy in nodular melanoma

0306: Melanoma Antigen Gene (Mage) Can Be a Good Target of Immunotherapy in Old Patients with Aggressive Ovarian Cancer

0470: Lymph Node Ratio (Lnr) is a Usefull Prognostic Factor in Node-Positive Primary Vulvar Malignant Melanoma (Pvmm)

0527: Primary Melanoma of the Uterine Cervix

0542: Malignant Vaginal Melanoma: a Case Report

0554: Malignant Melanoma of the Vagina - Analysis of Prognostic Factors

062 Pembrolizumab induced lambert-eaton myasthenic syndrome

09.02 Bispecific antibodies enable synthetic agonistic receptor T cell therapy in melanoma

09.04 Secondary resistance to immunotherapy is associated with death and de-differentiation of activated T cells

0D/2D heteronanostructure–integrated bimetallic CoCu-ZIF nanosheets and MXene-derived carbon dots for impedimetric cytosensing of melanoma B16-F10 cells

1,2,3-Triazolyl esterization of PAK1-blocking propolis ingredients, artepillin C (ARC) and caffeic acid (CA), for boosting their anti-cancer/anti-PAK1 activities along with cell-permeability

1-(2,4-Dihydroxyphenyl)-3-(2,4-dimethoxy-3-methylphenyl)propane, a Novel Tyrosinase Inhibitor with Strong Depigmenting Effects

1,2,4-Trimethoxybenzene selectively inhibits NLRP3 inflammasome activation and attenuates experimental autoimmune encephalomyelitis

1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylamino)carbonylhydrazine (101M) : A novel sulfonylhydrazine prodrug with broad-spectrum antineoplastic activity

1,2-Bis(sulfonyl)hydrazines. 3. Effects of structural modification on antineoplastic activity

1,2-Dihydroxyxanthone: Effect on A375-C5 Melanoma Cell Growth Associated with Interference with THP-1 Human Macrophage Activity

1,25‐Dihydroxyvitamin D 3 enhances NK susceptibility of human melanoma cells via Hsp60‐mediated FAS expression

1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture

1,25-Dihydroxyvitamin D3 decreases expression of HLA class II molecules in a melanoma cell line

1,25‐Dihydroxyvitamin D3 enhances NK susceptibility of human melanoma cells via Hsp60‐mediated FAS expression

1,25-dihydroxyvitamin D3 enhances the growth of tumors in athymic mice inoculated with receptor rich osteosarcoma cells

1,25-dihydroxyvitamin D3 receptors in human carcinomas : a pilot study

1,25-dihydroxyvitamin D3 receptors in human epithelial cancer cell lines

Suchergebnisse filtern